Haplotype-based case-control study between human apurinic/apyrimidinic endonuclease 1/redox effector factor-1 gene and cerebral infarction

Clinical Biochemistry

Volumn 42, Issue 15, 2009, Pages 1493-1499

  Naganuma, Takahiro ^a,b   Nakayama, Tomohiro ^a   Sato, Naoyuki ^a   Fu, Zhenyan ^a   Yamaguchi, Mai ^a   Soma, Masayoshi ^a   Aoi, Noriko ^a   Usami, Ron ^b   Doba, Nobutaka ^c   Hinohara, Shigeaki ^c  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOYO UNIVERSITY   (Japan)

^c Life Planning Center   (Japan)

Author keywords

Apurinic apyrimidinic endonuclease 1 redox effector factor 1; Case control study; Cerebral infarction; Haplotype; Single nucleotide polymorphism

Indexed keywords

APURINIC APYRIMIDINIC ENDONUCLEASE 1; CYTOSINE; ENDONUCLEASE; GUANINE; REDOX EFFECTOR FACTOR 1; THYMINE; UNCLASSIFIED DRUG;

AGED; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; GENES, RAS; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STROKE;

EID: 70249118874     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.07.016     Document Type: Article

References (31)

1. Kubo M., Hata J., Ninomiya T., et al. A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat. Genet. 39 (2007) 212-217
2. Dominiczak A.F., Negrin D.C., Clark J.S., et al. Genes and hypertension from gene mapping in experimental models to vascular gene transfer strategies. Hypertension 35 (2000) 164-172
3. Evans A.R., Limp-Foster M., and Kelley M.R. Going APE over ref-1. Mutat. Res. 461 (2000) 83-108
4. Qu J., Liu G.H., Huang B., et al. Nitric oxide controls nuclear export of APE1/Ref-1 through S-nitrosation of cysteines 93 and 310. Nucleic Acids Res. 35 (2007) 2522-2532
5. Fritz G. Human APE/Ref-1 protein. Int. J. Biochem. Cell Biol. 32 9 (2000) 925-929
6. Yang S., Irani K., Heffron S.E., et al. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor. Mol. Cancer Ther. 4 (2005) 1923-1935
7. Robson C.N., Hochhauser D., Craig R., et al. Structure of the human DNA repair gene HAP1 and its localisation to chromosome 14q 11.2-12. Nucleic Acids Res. 20 (1992) 4417-4421
8. Xanthoudakis S., Miao G.G., and Curran T. The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 23-27
9. Jeon B.H., Gupta G., Park Y.C., et al. Apurinic/apyrimidinic endonuclease 1 regulates endothelial NO production and vascular tone. Circ. Res. 95 (2004) 902-910
10. Umemoto S., Tanaka M., Kawahara S., et al. Calcium antagonist reduces oxidative stress by upregulating Cu/Zn superoxide dismutase in stroke-prone spontaneously hypertensive rats. Hypertens. Res. 27 (2004) 877-885
11. Tanaka M., Umemoto S., Kawahara S., et al. Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats. Hypertens. Res. 28 (2005) 67-77
12. Volpe M., Alderman M.H., Furberg C.D., et al. Beyond hypertension toward guidelines for cardiovascular risk reduction. Am. J. Hyperens. 17 (2004) 1068-1074
13. Negishi H., Ikeda K., Kuga S., et al. The relation of oxidative DNA damage to hypertension and other cardiovascular risk factors in Tanzania. J. Hypertens. 19 (2001) 529-533
14. Patterson C. Blood pressure control goes nuclear. Circ. Res. 95 (2004) 849-851
15. Nakayama T., Soma M., Rehemudula D., et al. Association of 5′ upstream promoter region of prostacyclin synthase gene variant with cerebral infarction. Am. J. Hypertens. 13 (2000) 1263-1267
16. Baum L., Ng H.K., Woo K.S., et al. Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk. Clin. Biochem. 39 (2006) 191-195
17. Sano M., Kuroi N., Nakayama T., et al. Association study of calcitonin-receptor-like receptor gene in essential hypertension. Am. J. Hypertens. 18 (2005) 403-408
18. Saito K., Miyake S., Moriya H., et al. Detection of the four sequence variations of MDR1 gene using TaqMan MGB probe based real-time PCR and haplotype analysis in healthy Japanese subjects. Clin. Biochem. 36 (2003) 511-518
19. Morita A., Nakayama T., Soma M., et al. Association between the calcitonin-related peptide alpha (CALCA) gene and essential hypertension in Japanese subjects. Am. J. Hypertens. 20 (2007) 527-532
20. Morita A., Nakayama T., and Soma M. Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. Am. J. Hypertens. 19 (2006) 593-600
21. Yu Z., Chen J., Shi H., et al. Analysis of GABRB2 association with schizophrenia in German population with DNA sequencing and one-label extension method for SNP genotyping. Clin. Biochem. 39 (2006) 210-218
22. Chang-Claude J., Popanda O., Tan X.L., et al. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin. Cancer Res. 11 (2005) 4802-4809
23. Su D., Ma S., Liu P., et al. Genetic polymorphisms and treatment response in advanced non-small cell lung cancer. Lung Cancer 56 (2007) 281-288
24. Pardini B., Naccarati A., Novotny J., et al. DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat. Res. 638 (2008) 146-153
25. Fujimura M., Morita-Fujimura Y., Kawase M., et al. Early decrease of apurinic/apyrimidinic endonuclease expression after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19 (1999) 495-501
26. Kawase M., Fujimura M., Morita-Fujimura Y., et al. Reduction of apurinic/apyrimidinic endonuclease expression after transient global cerebral ischemia in rats: implication of the failure of DNA repair in neuronal apoptosis. Stroke 30 (1999) 441-448
27. Edwards M., Kent T.A., Rea H.C., et al. APE/Ref-1 responses to ischemia in rat brain. Neuroreport 9 (1998) 4015-4018
28. Hopmeier P., Puehringer H., van Trotsenburg M., et al. Association of endothelial protein C receptor haplotypes, factor V Leiden and recurrent first trimester pregnancy loss. Clin. Biochem. 41 (2008) 1022-1024
29. Morris R.W., and Kaplan N.L. On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet. Epidemiol. 23 (2002) 221-233
30. Sharma P., Hingorani A., Jia H., et al. Quantitative association between a newly identified molecular variant in the endothelin-2 gene and human essential hypertension. J. Hypertens. 17 (1999) 1281-1287
31. Ombra M.N., Forabosco P., Casula S., et al. Identification of a new candidate locus for uric acid nephrolithiasis. Am. J. Hum. Genet. 68 (2001) 1119-1129